Q1 FY27 results: Revenue up 15 percent, PAT jumps 43 percent YoY standalone
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Metropolis Healthcare Q1 FY27 standalone: revenue rose 15 percent YoY to Rs 3,723M; PAT grew about 43 percent to Rs 507M (EPS Rs 2.44 vs Rs 1.73). Consolidated revenue grew 16.6 percent to Rs 4,502M; PAT up 25.7 percent at Rs 569M (EPS Rs 2.73). No exceptional items this quarter. Auditor BSR and Co issued unmodified review report. Sale of External Quality Assessment Services business to wholly owned subsidiary delayed by 2 months. Bonus shares 3:1 were issued in FY26.
Strong Q1 with double-digit revenue and profit growth; business transfer delay is minor; overall positive earnings momentum for shareholders.